Contacto
Campos de conocimiento
Bioquímica
Biotecnología
Farmacología
Neurobiología
Líneas de investigación
Inmunoterapia para la enfermedad de Alzheimer. Neuroinflamación.
Publicaciones
46. Nava Catorce M, Gevorkian G*(corresponding author). LPS-induced murine neuroinflammation model: main features and suitability for preclinical assessment of nutraceuticals. Current Neuropharmacology 14: 155-164, 2016. FI: 4.57.
47. Nava Catorce M, Acero G, Pedraza-Chaverri J, Fragoso G, Govezensky T, Gevorkian G* (corresponding author). Alpha-mangostin attenuates brain inflammation induced by peripheral lipopolysaccharide administration in C57BL/6J. Journal of Neuroimmunology 297: 20-27, 2016. FI: 2.83.
48. Servín-Blanco R, Zamora-Alvarado R, Gevorkian G, Manoutcharian K. Antigenic variability: Obstacles on the road to vaccines against traditionally difficult targets. Human Vaccines and Immunotherapeutics 12: 2640-2648, 2016. FI: 2.59.
49. Meneses G, Bautista M, Florentino A, Diaz G, Acero G, Besedovsky H, Meneses D, Fleury A, Gevorkian G, Fragoso G, Sciutto, E. Electric stimulation of the vagus nerve reduced mouse neuroinflammation induced by lipopolysaccharide. Journal of Inflammation (London) 13: 33, 2016. FI: 2.66.
50. Manoutcharian K, Perez-Garmendia R, Gevorkian G.* (corresponding author). Recombinant antibody fragments for neurodegenerative diseases. Current Neuropharmacology 15: 779-788, 2017. FI: 4.57.
51. Martino Adami PV, Galeano P, Wallinger ML, Quijano C, Rabossi A, Pagano ES, Olivar N, Reyes Toso C, Cardinali D, Brusco LI, Do Carmo S, Radi R, Gevorkian G, Castaño EM, Cuello AC, Morelli L. Worsening of memory déficit induced by energy-dense diet in a rat model of early-Alzheimer´s disease is associated to neurotoxic Ab species and independent of neuroinflammation. BBA- Molecular Basis of Disease 1863: 731-743, 2017. FI: 5.15.
52. Acero G, Nava Catorce M, Gonzalez-Mendoza R, Meraz-Rodriguez MA, Hernandez-Zimbron LF, Gonzalez-Salinas R, Gevorkian G* (corresponding author). Sodium thiosulphate attenuates brain inflammation induced by systemic lipopolysaccharide administration in C57BL/6J mice. Inflammopharmacology 25: 585-593, 2017. FI: 3.84.
53. Meneses G, Gevorkian G, Florentino A, Bautista MA, Espinosa A, Acero G, Diaz G, Fleury A, Perez Osorio IN, Del Rey A, Fragoso G, Sciutto E, Besedovsky H. Intranasal delivery of dexamethasone efficiently controls LPS-induced murine neuroinflammation. Clin Exp Immunol 190: 304-314, 2017. FI: 3.71.
54. Bobes RJ, Navarrete-Perea J, Ochoa-Leyva A, Anaya VH, Hernandez M, Cervantes-Torres J, Estrada K, Sanchez-Lopez F, Soberon X, Rosas G, Maroni Nunes C, Garcia-Varela M, Sotelo-Mundo RR, Lopez-Zavala AA, Gevorkian G, Acero G, Laclette JP, Fragoso G, Sciutto E. Experimental and Theoretical approaches to investigate the immunogenicity of Taenia solium-derived KE7 antigen. Infection and Immunity 85: e00395-17, 2017. FI: 3.16.
55. Gonzalez-Castro R, Acero Galindo G, Garcia Salcedo Y, Uribe Campero L, vazquez perez V, Carillo-Tripp M, Gevorkian G, Gomez Lim MA. Plant-based chimeric HPV-virus-like particles bearing amyloid-beta epitopes elicit antibodies able to recognize amyloid plaques in APP-tg mouse and Alzheimer´s disease brains. Inflammopharmacology 26: 817-827, 2018. FI: 3.84.
56. Servín-Blanco R, Chávaro-Ortiz RM, Zamora-Alvarado R, Martínez-Cortes F, Gevorkian G, Manoutcharian K. Generation of cancer vaccine immunogens derived from major histocompatibility complex (MHC) class I molecules using variable epitope libraries. Immunology Letters 204: 47-54, 2018. FI: 2.55.
57. Acero G, Garay C, Venegas D, Ortega E, Gevorkian G* (corresponding author). Novel monoclonal antibody 3B8 specifically recognizes pyroglutamate-modified amyloid β 3-42 peptide in brain of AD patients and 3xTg-AD transgenic mice. Neuroscience Letters 724: 134876, 2020. FI: 2.27.
58. Cruz-Reséndiz A, Zepeda-Cervantes J, Sampieri A, Bastián-Eugenio C, Acero G, Sánchez-Betancourt JI, Gevorkian G, Vaca L. A self-aggregating peptide: implications for the development of thermostable vaccine candidates. BMC Biotechnol 20: 1, 2020. FI: 2.31.
59. Catorce MN, Gevorkian G* (corresponding author). Evaluation of Anti-Inflammatory Nutraceuticals In Lps-Induced Mouse Neuroinflammation Model: An Update. Curr. Neuropharmacol. 18: 636-654, 2020. FI: 4.66
60. Domínguez-Romero AN, Martínez-Cortés F, Munguía ME, Odales J, Gevorkian G, Manoutcharian K. Generation of multiepitope cancer vaccines based on large combinatorial libraries of survivin-derived mutant epitopes. Immunology 161: 123-138, 2020. FI: 5.01.
61. Manoutcharian K, Guzman Valle J, Gevorkian G. Neoantigen cancer vaccines: real opportunity or another illusion? Archivum Immunologiae et Therapiae Experimentalis, 2021. In Press. FI:3.2.
62. Soto-Rojas LO, Campa-Córdoba BB, Harrington CR, Salas-Casas A, Hernandes-Alejandro M, Villanueva-Fierro I, Bravo-Muñoz M, Garcés-Ramírez H, De la Cruz F, Ontiveros-Torres MA, Gevorkian G, Pacheco-Herrero M, Luna-Muñoz J. Insoluble vascular amyloid deposits trigger diffusion of the neurovascular unit in Alzheimer's disease brains. International Journal of Molecular Sciences, 2021. In press. FI:4.55.
